DTDavid T. Tse

David T. Tse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David T. Tse has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Simple Maneuver to Reposit a Subluxed Globe

    by David T. Tse

    In patients with thyroid orbitopathy, severe lid retraction and proptosis may produce spontaneous axial globe subluxation. This acute event is characterized by anterior displacement of the globe beyond the orbital rim, retraction of both upper and lower eyelids behind the globe, and tethering of the optic nerve.1,2 This frightening occurrence causes severe pain because of exposure keratopathy and forward displacement of the globe, as the retracted eyelids are squeezing the retrobulbar tissues. Spontaneous globe subluxation frequently occurs at home or at work, and patients experiencing this for the first time often panic because they have never been forewarned of this possibility nor received any instruction on how to attend to such an emergency. The lack of concise patient instruction for a quick and safe method of self-administered globe reposition is the main impetus for the design of current technique.


  • Open Access

    Nasolacrimal Duct Obstruction and Orbital Cellulitis Associated With Chronic Intranasal Cocaine Abuse

    by George Alexandrakis, David T. Tse, Robert H. Rosa, Thomas E. Johnson

    COCAINE IS a naturally occurring alkaloid of the coca plant Erythroxylon coca. Its pharmacological properties are secondary to stimulation of the central and sympathetic nervous systems by augmenting the effects of norepinephrine. The use of cocaine as a topical anesthetic in ophthalmology was described by Koller1 in 1884. Topically applied cocaine causes mydriasis by blocking the reuptake of norepinephrine and is used in evaluating anisocoria. In a higher concentration, cocaine may cause cycloplegia and upper eyelid retraction.2


    • 1 May 1999
      • Vol. 15  (3) , 171-9

    Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients.

    by T E Johnson, D T Tse, G E Byrne, A Restrepo, C C Whitcomb, W Voigt, P Benedetto, V Curtin

    To determine whether molecular genetic analysis of ocular-adnexal lymphoid tumors, combined with histopathology and tumor location, is helpful in predicting which patients will develop systemic lymphoma. A combined retrospective and prospective study of 77 patients with ocular-adnexal lymphoid tumors was performed. The tumors were subdivided into conjunctival, orbital, and eyelid lesions, and all were studied using both routine histopathology and molecular genetic analysis. Most lesions (70%) were small cell lymphomas of the mucosa-associated lymphoid tissue type, and the majority of tumors (90%) contained monoclonal or oligoclonal populations of lymphocytes discovered on molecular genetic analysis. Additionally, 72% of tumors exhibiting clonality had more than one gene rearrangement. Fifty-three percent of patients developed extraocular lymphoma sometime during the course of their disease. Patients with gene rearrangements on Southern blot hybridization had a 52% incidence of nonocular disease, compared with 63% of those without rearrangements. Patients with conjunctival tumors had a 37.5% incidence of nonocular disease, those with orbital tumors had a 54% incidence, and those with eyelid tumors had a 100% incidence of nonocular lymphoma. Only two patients died as result of systemic lymphoma. Most ocular-adnexal lymphoid tumors are lymphomas of the mucosa-associated lymphoid tissue type. The majority of tumors exhibit gene rearrangements on molecular genetic analysis, and this technique was not helpful in predicting which patients would develop nonocular lymphoma. Tumor location did have predictive value: Conjunctival lesions had the lowest incidence of nonocular lymphoma, and lid lesions had the highest incidence. Even with disseminated disease, most patients have a favorable prognosis with treatment.


  • Open Access

    Neoadjuvant Intracarotid Chemotherapy for Treatment of Advanced Adenocystic Carcinoma of the Lacrimal Gland

    by Melissa L. Meldrum, David T. Tse, Pasquale Benedetto

    AN ADENOCYSTIC carcinoma of the lacrimal gland is the most common nonlymphoid malignant tumor of the lacrimal gland, accounting for 25% to 30% of epithelial lacrimal gland tumors.1 Despite extensive surgery and radiation therapy, the prognosis for these patients remains grim, with survival of less than 50% at 5 years and a dismal 20% at 10 years.2 In an effort to improve survival, we incorporated neoadjuvant intracarotid chemotherapy combined with intravenous chemotherapy into the conventional treatment for this disease.